CAS 1246814-59-4

Formule : C₂₆H₂₃Cl₂D₄N₅O₂

InChI : InChI=1S/C26H27Cl2N5O2/c1-4-33(5-2)13-14-35-19-11-9-18(10-12-19)30-26-29-16-17-15-20(25(34)32(3)24(17)31-26)23-21(27)7-6-8-22(23)28/h6-12,15-16H,4-5,13-14H2,1-3H3,(H,29,30,31)/i13D2,14D2

Code InChI : InChIKey=IFPPYSWJNWHOLQ-RYIWKTDQSA-N

SMILES : O=C1C(=CC=2C(N1C)=NC(NC3=CC=C(OC(C(N(CC)CC)([2H])[2H])([2H])[2H])C=C3)=NC2)C4=C(Cl)C=CC=C4Cl

PD-166285-d4

Produit contrôlé

CAS : 1246814-59-4

Applications A labelled broad-spectrum receptor tyrosine kinase (RTK) inhibitor which shows anti-angiogenic activity and anti-tumor efficacy in combination with photodynamic therapy (PDT).
References Star, W., et al.: Cancer Res., 46, 2532 (1986), Sawutz, D., et al.: Biochem. Pharm., 51, 1631 (1996), Voest, E., et al.: Anti-Cancer Drugs, 7, 723 (1996), Connolly, C., et al.: Bioorg. Med. Chem. Lett., 7(18), 2415 (1997), Hamby, J., et al.: J. Med. Chem., 40, 2296(1997),

Formule : C₂₆D₄H₂₃Cl₂N₅O₂

Couleur et forme : Neat

Masse moléculaire : 589.38

Ref: TR-P217502

PD-166285-d4

CAS : 1246814-59-4

Please enquire for more information about PD-166285-d4 including the price, delivery time and more detailed product information at the technical inquiry form on this page

Formule : C₂₆H₂₇Cl₂N₅O₂

Degré de pureté : Min. 95%

Masse moléculaire : 516.5 g/mol

Ref: 3D-WZB81459